BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7680440)

  • 1. [Combination external and internal radiotherapy for esophageal carcinoma: a new prospect].
    Caspers RJ; Zwinderman AH; Griffioen G; Welvaart K; Leer JW
    Ned Tijdschr Geneeskd; 1993 Feb; 137(9):465-8. PubMed ID: 7680440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
    Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
    Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraluminal high dose rate brachytherapy combined with external radiotherapy in the treatment of oesophageal cancer.
    Barone D; Coccia G; Marziano C; Tricerri R; Bonelli L; Tomassini E; Bistolfi F
    Panminerva Med; 1993 Jun; 35(2):86-92. PubMed ID: 8414629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
    Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
    Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with intraluminal radiotherapy in advanced oesophageal cancer.
    Mohanti BK; Shukla NK; Chawla S; Ganesh T; Deo SV; Thakur KK; Raina V; Mohanta PK; Rath GK
    Trop Gastroenterol; 1995; 16(1):27-32. PubMed ID: 7544039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation stenosis and fistula formation developed after iridium-192 high-dose-rate intracavitary radiation boost therapy for carcinoma of the esophagus].
    Onishi H; Ogata H; Uchiyama G; Yamaguchi M; Toyama K; Koizumi K; Monzawa S; Oba H; Kachi K; Araki T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Feb; 53(2):210-9. PubMed ID: 8488104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High-dose-rate brachytherapy in esophageal carcinoma: the Italian experience].
    Gava A; Fontan L; Bolner A; Botturi M; Cafaro I; Di Marco A; Marazzato G; Muto P; Orecchia R; Orsatti M; Parisi SS; Rigon A
    Radiol Med; 1996; 91(1-2):118-21. PubMed ID: 8614712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
    Hoskin PJ; de Canha SM; Bownes P; Bryant L; Glynne Jones R
    Radiother Oncol; 2004 Nov; 73(2):195-8. PubMed ID: 15542167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
    Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
    J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch].
    Mazeron JJ; Belkacemi Y; Simon JM; Le Péchoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynègre R; Le Bourgeois JP; Pierquin B
    Bull Cancer Radiother; 1996; 83(1):47-53. PubMed ID: 8679281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The results of the endoluminal high-dose-rate irradiation of central non-small cell bronchial carcinomas].
    Schraube P; Fritz P; Becker HD; Wannenmacher M
    Strahlenther Onkol; 1993 Apr; 169(4):228-34. PubMed ID: 8387698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocavitary radiotherapy in carcinoma oesophagus.
    Jha AK; Prasiko G; Mod H; Chaurasia PP; Srivastava E
    JNMA J Nepal Med Assoc; 2006; 45(161):173-7. PubMed ID: 17160092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of esophagogastroscopy in application and follow-up of high-dose-rate brachytherapy (HDRB) for treatment of esophageal carcinoma.
    Greene FL; Boulware RJ; Bianco J
    Surg Laparosc Endosc; 1995 Dec; 5(6):425-30. PubMed ID: 8611986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The multimodality therapy of advanced inoperable esophageal carcinoma. A retrospective analysis].
    Mücke R; Ziegler PG; Libera T; Klautke G; Fietkau R
    Strahlenther Onkol; 2000 Aug; 176(8):350-5. PubMed ID: 10987017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraluminal irradiation for T2M0 esophageal cancer: effect of patient selection on prognosis.
    Nakajima T; Fukuda H; Hosono M; Tsumura M; Tada T; Nishita T; Tashiro M; Hirokawa K; Onoyama Y
    Radiat Med; 1992; 10(3):123-8. PubMed ID: 1509104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy of esophageal cancer. Results following radiotherapy alone and simultaneous radiochemotherapy and intracavitary irradiation].
    Fietkau R; Grabenbauer GG; Sauer R
    Strahlenther Onkol; 1994 Feb; 170(2):69-78. PubMed ID: 8108784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term observation of 64 patients with roentgenographically occult lung cancer treated with external irradiation and intraluminal irradiation using low-dose-rate iridium.
    Fuwa N; Kodaira T; Tachibana H; Nakamura T; Tomita N; Daimon T
    Jpn J Clin Oncol; 2008 Sep; 38(9):581-8. PubMed ID: 18723609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.